Hardin Capital Partners, LLC Eli Lilly & CO Transaction History
Hardin Capital Partners, LLC
- $177 Billion
- Q3 2024
A detailed history of Hardin Capital Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hardin Capital Partners, LLC holds 1,289 shares of LLY stock, worth $1.07 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
1,289
Previous 1,286
0.23%
Holding current value
$1.07 Million
Previous $1.16 Billion
1.16%
% of portfolio
0.67%
Previous 0.76%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
3,920Shares Held
765MCall Options Held
6.38MPut Options Held
7.95M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$80.6 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$61.4 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$54.8 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$42.7 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$28.2 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $790B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...